RE:RE:RE:RE:RE:RE:RE:RE:RE:A few thoughtsThanks Jkj and GV.
"some impediment to the further DEVELOPEMENT of both entities by a third party acquirer or joint venturer, by the boards,
which has made irrational the attempted further DEVELOPEMENT of these entities by a third party Read more at https://www.stockhouse.com/companies/bullboard/t.rvx/resverlogix-corp#VYuwQVOsvcjivQL0.99" I did a post a number of months back because these intertwined relationships reminded me of a company that was significantly undervalued because investors and brokers could not understand the structure and thus couldn't value it.
So there may be suitors for RVX based on the sciientific results but are they being put off by the entanglement.
- In a CVR the buyer would own all of RVX and it's assets like patents and other intellectual property but what about things like the royalty flows, the 10 year office leases, what about the staff and scientists and there is probably lots of other stuff to untangle?
- In a straight trial funding based on shares and warrants I guess it is straight forward because they are getting shares and warrants of what RVX currently is.
If I was a large investor looking at this I would want to sort it out and get clarity.
So I sense they have created a structural mess that may be part of a barrier to a deal.
Toinv